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Background. +e optimal prescription of cueing for the treatment of freezing of gait (FoG) in Parkinson’s disease (PD) is currently
a difficult problem for clinicians due to the heterogeneity of cueing modalities, devices, and the limited comparative trial evidence.
+ere has been a rise in the development of motion-sensitive, wearable cueing devices for the treatment of FoG in PD. +ese
devices generally produce cues after signature gait or electroencephalographic antecedents of FoG episodes are detected (phasic
cues). It is not known whether these devices offer benefit over simple (tonic) cueing devices. Methods. We assembled 20
participants with PD and FoG and familiarized them with a belt-worn, laser-light cueing device (Agilitas™). +e device was
designed with 2 cueing modalities—gait-dependent or “phasic” cueing and gait-independent or “tonic” cueing. Participants used
the device sequentially in the off, phasic, or tonic modes, across 2 tasks—a 2-minute walk and an obstacle course. Results. A
significant improvement in mean distance walked during the 2-minute walk test was observed for the tonic mode (127.3m)
compared with the off (111.4m) and phasic (116.1m) conditions. In contrast, there was a nonsignificant trend toward im-
provement in FoG frequency, duration, and course time when the device was switched from off to tonic and to phasic modes for
the obstacle course. Conclusions. Parkinson’s disease patients with FoG demonstrated an improvement in distance walked during
the two-minute walk test when a cueing device was switched from off to phasic and to tonic modes of operation. However, this
benefit was lost when patients negotiated an obstacle course.
1. Introduction
Freezing of gait (FoG) is a common problem in people with
Parkinson’s disease (PD) and affects up to 87% of patients
who have lived with the disease for over 10 years [1]. Whilst
PD is a complex, multisystem disorder, FoG has been re-
ported to have a greater impact on quality of life than any
other symptom [2]. As the most common cause of falls in
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PD, FoG can have serious implications for patient mor-
bidity, mortality, and quality of life. +ese implications have
broader health economics consequences.
Current treatments for FoG generally involve manipu-
lation of daily levodopa dose and timing, coupled with
exercise and physiotherapy.+ere is also promising evidence
for amantadine, methylphenidate, and subthalamic nucleus
stimulation for the management of FoG, as well as case
report level evidence for serotonin and norepinephrine
reuptake inhibitors (SNRIs) [3, 4]. +e clinical benefit from
these interventions is often limited, and a clear need exists
for further research aimed at establishing the efficacy of
alternate methods of FoG management.
Cueing has long been recognized as a remarkably ef-
fective treatment in some patients with FoG [5]. However,
given the complex neurobiology of FoG, each patient may
respond differently to different cue modalities (e.g., visual,
auditory, somatosensory, or cognitive) [6]. To date, there are
no established predictors of patient responsiveness to a
specific cueing strategy. In a recent meta-analysis that
compared visual, auditory, and somatosensory cueing mo-
dalities, it was found that all three sensory modalities were
comparably effective in a laboratory environment [6]. In
contrast, an experimental study reported that visual cues
were superior to auditory and vibration cues at assisting
people with PD who had difficulties with gait initiation [7].
Unfortunately, the cues delivered in these studies were either
(i) fixed, (ii) used a predetermined pulse, or (iii) voluntarily
patient triggered. As such, much less is known about the
efficacy of motion-triggered (phasic) cues for managing
symptoms of FoG in people with PD. Ginis et al. [8, 9] have
identified that there are difficulties with the long-term con-
solidation and transfer of the effects of cueing and further
explored the possibilities that exist with advancing technol-
ogies, for the management of FoG with external cueing.
+e capacity for miniaturization of electronic compo-
nentry has spawned the rapid development of a new gen-
eration of patient-worn devices, which may be used as
cueing devices for the treatment of FoG [10–17]. A range of
algorithms for the detection of FoG and the provision of
gait-dependent cues are now in the public domain, and the
Bachlin–Moore algorithm continues to be improved
[10, 12]. In a recent meta-analysis of 23 studies [18], it was
shown that studies seeking to detect FoG episodes using
wearable sensors were highly variable with respect to the
body part used to detect the events. +ere was also a sig-
nificant degree of heterogeneity in the mode of cue delivery
between studies, with an increasingly complex matrix of
design options now available (e.g., modality, pulsed vs.
continuous, patient vs. gait-initiated, and mechanical-aid
associated). Collectively, these variables have made it diffi-
cult to determine the transferability of the reported out-
comes to the real-world environment. To progress this field,
there is a clear need for head to head comparative studies,
where cue modality and/or environment is manipulated, to
better understand the utility of cueing devices in all their
forms.
+e prescription of wearable devices for invivo use re-
mains a significant problem. It is, however, a laudable goal in
the knowledge that symptoms of FoG are generally most
troublesome for patients in their home environments [15].
While the field continues to move apace, fundamental
questions regarding the optimal prescription of cues in
specific environments need to be answered. Importantly, we
are unaware of how the newer motion-dependent tech-
nologies are compared with older technologies in simple
versus complex environments. Will the quest for smarter,
wearable cueing devices create a treatment that is of any
more use than the inexpensive technologies that already
exist? To begin to address this question, we designed a
laboratory-based experiment with contrasting environments
(simple and complex) to test the effectiveness of two dif-
ferent visual cueing modalities provided by a belt-worn
cueing device worn by a PD population with FoG.
2. Method
A case series of 20 people with PD who were assessed by 3
local movement disorder neurologists in Brisbane, Australia,
were included in the study. Patients were invited to par-
ticipate in the study, if they were determined by their
treating neurologist to have clinically significant FoG, and all
participants reported a score ≥3 on item 3 of the Freezing of
Gait Questionnaire [19] (Table 1). Participants were ex-
cluded if they had (i) a significant medical comorbidity that
compromised their mobility; (ii) any visual impairment not
corrected with lenses; or (iii) any significant cognitive im-
pairment (Mini Mental State Exam total score <25). +e
study’s protocol was registered with Clinicaltrials.gov
(NCT02356536) and approved by the Human Research
Ethics Committees at the three Brisbane-based hospitals
involved in the trial. All volunteers provided written in-
formed consent in accordance with the Declaration of
Helsinki.
Eligible participants completed the Freezing of Gait
Questionnaire [19] to establish the frequency and impact of
their FoG symptoms, while themotor subscale of the Unified
Parkinson’s Disease Rating Scale (UPDRS-III) was used to
determine the severity of their motor symptoms. Following
the assessments of symptom severity, participants were
asked to perform 2 walking tasks that included (i) the 2-
minute walk test (2MWT) and (ii) an obstacle course
(Figure 1). +e obstacle course involved standing from a
seated position, walking 7metres to an open doorway. After
passing through the doorway, participants turned left and
traversed an uneven walking surface, before weaving be-
tween four markers situated on the floor at 2-metre intervals.
Once the final marker had been passed, participants turned
left and made their way to a seat to sit down. Upon resting
their back against the backrest of the seat, participants were
asked to stand, turn 180° to their right, and walk towards a
chair situated 10metres away, at the other end of the room.
While walking to the chair, participants were required to
step over 4 foam obstacles that stood 0.15metres tall and
1metre apart. Before sitting, participants completed a full
360° turn in each direction.
While performing each of these tests, participants wore a
small belt-mounted device that was designed to detect the
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onset of FoG in people with PD using a series of in-
corporated microsensors (Figure 2). Specifically, this device
used built-in accelerometers and gyroscopes sampling at
25Hz to detect a series of signature kinematic patterns that
are known to be antecedents of FoG episodes. When the
device detected a kinematic pattern that was indicative of a
gait disruption that would typically precede a FoG episode,
an incorporated red-light laser pointer was triggered and
projected a red dot several metres in front of the participant.
While the light was active, the device continued to analyse
the data from the in-built sensors and once the data sug-
gested the resumption of steady state walking for at least 3
seconds, the light was extinguished, unless further triggered.
To limit the risk of the device not providing a visual cue when
an actual freezing episode occurred (i.e., false negatives), the
FoG detection algorithm was deliberately calibrated to favour
false positives (i.e., illuminating for complete and near FoG
episodes). In addition to the FoG detection mode (i.e., the
gait-dependent or “phasic” mode), it was also possible to set
the laser pointer to provide a continuous or “tonic” visual cue
or to switch it off. To evaluate the efficacy of the visual cueing
device and to objectively determine the differences between
phasic and tonic visual cueing modes, participants completed
the two walking tasks for each of the 3 visual cueing mo-
dalities (i.e., off, phasic, and tonic). All trials were video
recorded to assist with analysis, and to limit the potential
influence of a learning effect and/or fatigue on the reported
outcomes, the order of testing conditions was varied between
participants. To ensure that the participants were optimally
medicated at the time of testing, all procedures were un-
dertaken within 1 to 2 hours of the participants’ scheduled
levodopa intake.
Following data collection, an associate investigator
reviewed the video recordings of the 2MWTand the obstacle
course on two occasions separated by at least one week. At
each of these time points, the investigator identified the
number and duration of FoG episodes experienced by each
participant while performing the tasks with each of the
visual cueing modalities. Statistical comparison of the two
assessments indicated excellent intrarater reliability for the
quantification of both the number (ICC: 0.930 to 0.975) and
duration (ICC: 0.976 to 0.999) of FoG episodes for all visual
cueing modes. In addition to recording the number and
duration of freezing episodes, the distance covered by the
participants during the 2MWTwas also recorded in metres,
while the time taken to complete the obstacle course was
measured in seconds.
Table 1: Patient characteristics.
Mean (frequency) SD (% sample)
Age 70.1 7.2
Gender (male) 15 75
UPDRS-III 36.4 13.5
Falls Efficacy Scale 34.8 12.8
Freezing of Gait Questionnaire 14.3 4.4
Montreal Cognitive Assessment 26.5 2.5






















Figure 1: Schematic drawing of the 33-metre obstacle course.
Figure 2: +e belt-worn freeze-detecting visual cueing device.
Note: the image shows the pilot light pointing upwards. By turning




+e Shapiro–Wilk test was used to confirm that the primary
outcomes were not normally distributed (p< 0.05) and
supported the decision to use nonparametric statistical
procedures. To statistically compare any mean differences
between the off, phasic, and tonic visual cueing modalities
for the frequency and duration of freezing episodes, the
distance covered during the 2MWT, and/or the time taken to
complete the obstacle course, the Friedman test was used.
When a significant main effect was identified for cue type,
pairwise comparisons were conducted with the Wilcoxon
signed-rank test to further explore differences between the
different visual cueing modalities. All statistical procedures
were conducted using SPSS v.24, and the level of significance
was set at p< 0.05.
4. Results
+e results of the statistical analyses indicated that, while
there was a gradient of improvement from the off to phasic
and to tonic modes for all three measures, neither the
frequency nor the duration of FoG episodes recorded during
the 2MWT reached statistical significance (Table 2). How-
ever, a significant main effect was returned for distance
walked by the patients during the 2MWT, with pairwise
comparisons indicating that the participants walked further
with the tonic visual cue compared with the off (p � 0.026)
and phasic (p � 0.008) visual cue modalities.
While negotiating the obstacle course, there was no
statistically significant improvement in FoG frequency
(p � 0.192), FoG duration (p � 0.173), and course time
(p � 0.357) from the off condition to the tonic condition and
the phasic condition (Table 3).
Whilst ultimately proving to be underpowered, due to
the small differences in performance across modalities, the
joint probability of the observed gradients of the 18 means
across both courses was p< 0.001 (0.00002).
5. Discussion
Although FoG is a disabling and common problem in PD,
there is a growing body of evidence for the benefits of cueing
strategies in its treatment [6]. Specifically, previous research
reports that the use of external cues can improve a range of
gait parameters in PD patients, including gait speed, stride
length, step variability, and cadence [20]. It is not known,
however, whether cueing that is triggered in response to the
specific kinematic events that precede the occurrence of a
FoG episode is more effective than cueing that is fixed and
independent of the FoG episode. Furthermore, it is not
known how environment complexity may impact the ef-
fectiveness of these two cue modalities. While there is no
accepted terminology for fixed versus motion-sensitive cues,
we have chosen the terms “tonic” and “phasic” cueing as we
believe these to be apt and widely understood terms that
have historical neurophysiological meaning.
+e results of our study showed that PD patients with
FoG walked a greater distance during a 2-minute walk test
with a tonic visual cue, compared with both the off
(p � 0.026) and phasic (p � 0.008) cueing conditions. Be-
cause the distance walked improved but not the FoG du-
ration and frequency, one explanation could be that the
tonic availability of a visual cue for participants simply
increased step amplitude and inhibited the sequence effect
known to precede FoG. However, when subjects were asked
to complete an obstacle course, there was a nonstatistically
significant reduction of freezing episodes, freezing times,
and course completion times when the device was switched
from the off to tonic and to phasic modes.
Taken together, these results may suggest a superiority of
a tonic cueing strategy in the simple environment of the 2-
minute walk task but not in the complex environment of the
obstacle course. While main effect measures and pairwise
comparison of means were otherwise nonsignificant, it bears
consideration that the differential gradients observed for
every measure favoured tonic cueing during the simple
2MWT, while phasic cueing was better in the complex
obstacle course. +e reduced benefit of tonic cueing during
the obstacle course could point to an influence of “envi-
ronmental attention burden” on the cue’s effectiveness and
possibly shines further light on the pathophysiology of FoG
and the mechanism of action of cueing.
+ere are currently four prevailing models that are used
to understand the phenomenon of FoG [21]: (i) the
threshold model; (ii) the neural reserve model; (iii) the
cognitive model; and (iv) the decoupling model. However,
the complex findings presented in this study do not spe-
cifically fit with any of these models and, hence, leads us to
speculate that the central place of attention and attention
regulation may be sufficiently important to warrant the
proposition of a fifth distinct “Bayesian” model. +ere has
been an increasing interest in conceptualizing neurological
function and dysfunction through the lens of Bayes’ theorem
[22]. In the neurosciences, the approach has been useful, with
the notion that the reconciliation of priors (that is, previously-
encoded programs) with current data (that is, sensory input)
can go awry. Attention acts as the modulator between these
two domains, and it appears that the model fits with what is
observed in FoG and may be supported by our findings.
Freezing occurs as an intermittent, dynamic process,
precipitated by events thought to confer attentional cost to
the subject, such as dual tasking, anxiety, or turning. It arises
in a setting where there is already a loss of gait automaticity.
Our findings pose the question of whether the disruption of
misplaced attention brought on by cueing somehow facili-
tates a return to automaticity or a cortical takeover of the
movement as suggested by Plotnik et al. [23].
Recent work utilizing virtual reality paradigms and fMRI
scanning in simulated FoG shows an impaired “change”
activation in the pre-supplementary motor area (SMA)
region purported to be due to reduced feed-forward pro-
cessing [24]. Circumstances requiring internally driven
motor control (priors) are known to utilize bottom-up,
dorsal visual pathways, described as covert attention. It is
suggested that it is this covert attention that requires support
and that it may be plausible that visual cueing’s mechanism
of action is through supporting this system.
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Although untestable in a moving patient, it seems likely
that tonic cueing may provide more optimal attention
network and pre-SMA support in a simple environment and
facilitate a return to automaticity and motor priors. In a
more complex environment, such as an obstacle course with
greater attentional demands, attention must be made
available for current environmental sensory data in pref-
erence to motor priors. As such, a tonic visual cue would not
suffice in this setting and another mechanism would be
needed.
Plotnik et al. [23] suggested that a cortical takeover of
movement occurs with cueing. +e question arises as to
whether a cortical takeover or a return to automaticity might
predominate and whether this is dependent on the attention
burden of the environment being negotiated.
6. Conclusions and Future Directions
+is study suggests a superiority of tonic visual cueing over
phasic or no visual cueing in a PD population with FoG
when performing a 2-minute walk test in a simple envi-
ronment. However, this finding was not maintained in the
complex environment of an obstacle course in the same
population. A nonsignificant differential gradient of im-
provement of all measures favouring tonic cueing in a simple
environment and phasic cueing in a complex environment
was observed. +is may have implications for the use of
visual cueing as a treatment for FoG in PD populations.
Further research is needed to consolidate this study’s
findings and determine whether there is benefit of phasic
cueing over both continuous and pulsed tonic cueing.
Furthermore, there is a clear need for studies to examine the
effectiveness of patient-worn cueing devices for a longer
duration of time, in a home environment, where freezing is
often worse.
For this to be achievable, beyond the detection of an-
tecedents of an impending freeze, the device would need to
be capable of reliably detecting and measuring the FoG
episodes themselves, to meaningfully function as a remote
patient monitoring device. Given the heterogeneity of FoG,
this task represents a significant challenge but is an exciting
prospect in the treatment of these symptoms.
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